Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Albireo Pharma Inc (NASDAQ: ALBO)

 
ALBO Technical Analysis
5
As on 2nd Mar 2023 ALBO STOCK Price closed @ 44.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 26.96 & Strong Buy for SHORT-TERM with Stoploss of 29.16 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALBOSTOCK Price

Open 44.90 Change Price %
High 44.90 1 Day -0.10 -0.23
Low 44.00 1 Week 0.39 0.89
Close 44.15 1 Month 0.27 0.62
Volume 1236106 1 Year 15.27 52.87
52 Week High 44.95 | 52 Week Low 16.32
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LMDX 0.02 0.00%
LCID 3.20 3.23%
AVGR 1.45 126.56%
NVDA 140.22 0.39%
AKTS 0.04 0.00%
TNXP 0.39 -2.50%
PONO 1.72 2.38%
TELL 1.00 0.00%
TSLA 462.28 7.36%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
GOEV 1.46 1725.00%
CLEU 2.63 1543.75%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
BAOS 8.24 390.48%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
MINM 0.15 -51.61%
LOTZW 0.01 -50.00%
HYZNW 0.01 -50.00%
 
 
ALBO
Daily Charts		 ALBO
Intraday Charts		 Whats New @
Bazaartrend		 ALBO
Free Analysis
 
ALBO Important Levels Intraday
RESISTANCE45.88
RESISTANCE45.33
RESISTANCE44.98
RESISTANCE44.64
SUPPORT43.66
SUPPORT43.32
SUPPORT42.97
SUPPORT42.42
 
ALBO Forecast December 2024
Share
4th UP Forecast60.91
3rd UP Forecast55.54
2nd UP Forecast52.21
1st UP Forecast48.89
1st DOWN Forecast39.41
2nd DOWN Forecast36.09
3rd DOWN Forecast32.76
4th DOWN Forecast27.39
 
ALBO Weekly Forecast
4th UP Forecast50.88
3rd UP Forecast48.72
2nd UP Forecast47.39
1st UP Forecast46.05
1st DOWN Forecast42.25
2nd DOWN Forecast40.91
3rd DOWN Forecast39.58
4th DOWN Forecast37.42
 
ALBO Forecast2024
4th UP Forecast100.44
3rd UP Forecast82.39
2nd UP Forecast71.23
1st UP Forecast60.07
1st DOWN Forecast28.23
2nd DOWN Forecast17.07
3rd DOWN Forecast5.91
4th DOWN Forecast-12.14
 
 
ALBO Other Details
Segment EQ
Market Capital 560151232.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALBO Address
ALBO
 
ALBO Latest News
 
Your Comments and Response on Albireo Pharma Inc
 
ALBO Business Profile
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transporter (IBAT) inhibitor that is in phase III clinical trial for treating patients with progressive familial intrahepatic cholestasis, as well as for treating biliary atresia, alagille syndrome, and other cholestatic liver diseases. The company is also developing Elobixibat for the treatment of chronic constipation and other functional diseases, and nonalcoholic steatohepatitis. It has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. The company is headquartered in Boston, Massachusetts. Address: 10 Post Office Square, Boston, MA, United States, 02109
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service